Every 10-Q that Olaplex Holdings, Inc. (OLPX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow OLPX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OLPX filings page.
Olaplex Holdings, Inc. reported a Q1 2026 net loss while advancing a proposed cash acquisition by Henkel US Operations Corporation at $2.06 per share.
Net sales rose to $99.4 million, up 2.5% year over year, as professional channel revenue grew 12.3% and DTC 13.8%, partly offset by a 13.3% decline in specialty retail. Gross margin improved to 72.1% from 69.5% due to mix and lower inventory write-offs.
Higher selling, general and administrative expenses of $66.0 million, driven by $7.4 million of merger-related costs, increased marketing and higher payroll, led to a net loss of $5.3 million versus a small profit a year earlier. The company ended the quarter with $326.2 million in cash, $354.8 million of term loan debt and total available liquidity of about $525 million including its undrawn revolver. The Henkel merger faces customary regulatory and closing conditions, an outside completion date of March 31, 2027 (extendable to September 30, 2027), and includes a potential $40.44 million termination fee and amendments to Olaplex’s Tax Receivable Agreement.
Olaplex Holdings (OLPX) reported Q3 2025 results. Net sales were $114.6 million versus $119.1 million a year ago as specialty retail and DTC softened, while professional channel sales grew. Gross margin improved to 69.1%, but higher selling, general and administrative costs—driven by a $9.3 million expense for the Purvala IPR&D asset acquisition and increased marketing and payroll—reduced operating income to $4.2 million from $28.0 million.
Net income was $11.1 million ($0.02 diluted EPS) versus $14.8 million, aided by a $9.5 million non‑cash reduction to the Tax Receivable Agreement liability related to the OBBBA. The company voluntarily repaid $300.0 million on its 2022 Term Loan Facility, lowering long‑term debt to $352.1 million and interest expense, with cash and cash equivalents at $286.4 million as of September 30, 2025.
Olaplex accrued $47.5 million for a pending settlement in the Lilien matter and recorded a $46.8 million insurance receivable. Q3 channel mix: Professional $44.5 million, Specialty retail $36.9 million, DTC $33.3 million. Shares outstanding were 667,431,776 as of September 30, 2025.